Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-017-3109-4
Published Online: 2017-08-22
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Phipps, C.
Yeoh, K. W.
Lee, Y. S.
Nagarajan, C.
Gopalakrishnan, S.
Ho, L. P.
Hwang, W. Y. K.
Goh, Y. T.
Grigoropoulos, N. F.
Funding for this research was provided by:
National Medical Research Council (NMRC/TA/0051/2016)
License valid from 2017-08-22